This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Myasthenic Syndromes, Congenital
Information about Myasthenic Syndromes, Congenital: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Myasthenic Syndromes, Congenital
Most recent studies have shown that Myasthenic Syndromes, Congenital shares some biological mechanisms with acetylcholinesterase-deficiency, apnea, atrophy, autoimmune-reaction, blepharoptosis, fatigability, hereditary-diseases, lambert-eaton-myasthenic-syndrome, muscle-hypotonia, muscle-weakness, muscular-atrophy, muscular-dystrophy, myasthenia-gravis, myasthenias, myopathy, neuromuscular-diseases, neuromuscular-junction-diseases, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Myasthenic Syndromes, Congenital, and have been seen in publications frequently: Brain Development, Cell Activation, Cell Adhesion, Cell Death, Endocytosis, Exocytosis, Gene Silencing, Glycosylation, Localization, Muscle Contraction, Neuromuscular Junction Development, Pathogenesis, Programmed Cell Death, Protein Glycosylation, Receptor Clustering, Rna Interference, Signal Transmission, Swimming, Synaptic Transmission, Transport
Quite a number of genes have been found to play important roles in Myasthenic Syndromes, Congenital, such as ACHE, AGRN, BCHE, CHAT, CHRNA1, CHRNE, COLQ, DBI, DOK7, MUSK, RAPSN, SCN4A, SH2D3C. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.